Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Provisio Medical has developed the SLT IVUS™ System, a novel intravascular ultrasound technology that enables accurate vessel sizing during endovascular procedures. The system received FDA clearance in April/May 2024 and is designed to improve clinical outcomes by providing real-time, user-independent measurements for physicians treating vascular diseases. The company is now commercializing its technology and expanding manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Provisio Medical.